顽固性ITP的原因与治疗

王兆钺

doi:10.13201/j.issn.1004-2806.2016.03.023

顽固性ITP的原因与治疗

王兆钺^,

- 1 苏州大学附属第一医院, 江苏省血液研究所;
- 卫生部血栓与止血重点实验室, 血液学协同创新中心(江苏苏州, 215006)
基金项目:
江苏省科教兴卫工程-临床医学中心(No:ZX201102)

江苏省血液病临床医学研究中心(江苏省科技厅生命健康专项-BL2012005)

详细信息

通讯作者: 王兆钺,E-mail:zwang11@sina.com

中图分类号: R558.2

收稿日期: 2015-03-31

Causes of refractory immune thrombocytopenia and its management

WANG Zhaoyue^,

More Information

Corresponding author: WANG Zhaoyue, E-mail: zwang11@sina.com

Received Date: 31 March 2015

摘要

- 免疫性血小板减少症,顽固性 /
- 原因 /
- 治疗
Abstract: Refractory immune thrombocytopenia(ITP)is defined by the patients who meet the criteria for severe ITP and have failed to splenectomy.Refractory ITP may be related to many different conditions such as accessory spleen,other causes of non-ITP thrombocytopinea and misdiagnosis.The options for the management of these patients are limited.Removing accessory spleen as well as thrombopoietin-receptor agonists and rituximab could represent reasonable salvage treatment,and they should be treated individually.
- refractory immune thrombocytopenia /
- causes /
- treatment

HTML全文

参考文献(28)

[1]	Neunert C,Lim W,Crowther M,et al.The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J].Blood,2011,117:4190-4207.
[2]	中华医学会血液学分会血栓与止血学组.成人原发免疫性血小板减少症诊治的中国专家共识(修订版)[J].中华血液学杂志,2011,32(3):214-216.
[3]	Kojouri K,Vesely SK,Terrell DR,et al.Splenectomy for adult patients with idiopathic thrombocytopenic purpura:a systematic review to assess long-term platelet count responses,prediction of response,and surgical complications[J].Blood,2004,104:2623-2634.
[4]	Rijcken E,Mees ST,Bisping G,et al.Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP):a retrospective cohort study on longtime response predicting factors based on consensus criteria[J].Int J Surg,2014,12:1428-1433.
[5]	Provan D,Stasi R,Newland AC,et al.International consensus report on the investigation and management of primary immune thrombocytopenia[J].Blood,2010,115:168-186.
[6]	Phom H,Kumar A,Tripathi M,et al.Comparative evaluation of Tc-99m-heat-denatured RBC and Tc-99m-anti-D IgG opsonized RBC spleen planar and SPECT scintigraphy in the detection of accessory spleen in postsplenectomy patients with chronic idiopathic thrombocytopenic purpura[J].Clin Nucl Med,2004,29:403-409.
[7]	Li J,Wang Z,Dai L,et al.Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.clinical and developmental immunology[J].Clin Dev Immunol,2013,2013:548085.
[8]	Wang Z,Cao L,Su Y,et al.Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia[J].Am J Hematol,2014,89:320-324.
[9]	Scheinberg P,Young NS.How I treat acquired aplastic anemia[J].Blood,2012,120:1185-1196.
[10]	Gyan E,Dreyfus F,Fenaux P.Refractory thrombocytopenia and neutropenia:a diagnostic challenge[J].Mediterr J Hematol Infect Dis,2015,7:e2015018.
[11]	Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumors of haematopoietic and lymphoid tissues[M].WHO,Lyon:IARC Press,2008.
[12]	Yamada EJ,Souto AF,de Souza E,et al.Pseudothrombocytopenia in a patient undergoing splenectomy of an accessory spleen[J].Rev Bras Anestesiol,2008,58:488-491.
[13]	Roca M,Muniz-Diaz E,Mora J,et al.The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia[J].Am J Hematol,2011,86:909-913.
[14]	Zeng Q,Zhu L,Tao L,et al.Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbalpha antibodies[J].Am J Hematol,2012,87:206-208.
[15]	Nieswandt B,Bergmeier W,Rackebrandt K,et al.Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice[J].Blood,2000,96:2520-2527.
[16]	van Der Wal DE,Zhu G,Li J,et al.Desialylation:a novel platelet clearance mechanism and a potential new therapeutic target in anti-GPIb antibody mediated thrombocytopenia[J].54th ASH Annual Meeting and Exposition,2012:Abstract 265.
[17]	Li J,Callum JL,Lin Y,et al.Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage[J].Haematologica,2014,99:e61-e63.
[18]	Alioglu B,Tasar A,Ozen C,et al.An experience of oseltamivir phosphate (tamiflu^TM) in a pediatric patient with chronic idiopathic thrombocytopenic purpura:a case report[J].Pathophysiol Haemost Thromb,2010,37:55-58.
[19]	Shao L,Wu Y,Zhou H,et al.Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody[J].Platelets,2014,28:1-3.
[20]	Grozovsky R,Begonja AJ,Liu K,et al.The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling[J].Nat Med,2015,21:47-54.
[21]	Altaf AM,Sawatzky M,Ellsmere J,et al.Laparoscopic accessory splenectomy:the value of perioperative localization studies[J].Surg Endosc,2009,23:2675-2679.
[22]	Boyers D,Jia X,Crowther M,et al.Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP)[J].Health Technol Assess,2011,15:23-32.
[23]	Choe MJ,Packer CD.Severe romiplostim-induced rebound thrombocytopenia after splenectomy for refractory ITP[J].Ann Pharmacother,2015,49:140-144.
[24]	Aleem A,Alaskar AS,Algahtani F,et al.Rituximab in immune thrombocytopenia:transient responses,low rate of sustained remissions and poor response to further therapy in refractory patients[J].Int J Hematol,2010,92:283-288.
[25]	Tran H,Brighton T,Grigg A,et al.A multi-centre,single-arm,open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory,relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)[J].Br J Haematol,2014,167:243-251.
[26]	Arnold DM,Nazi I,Santos A,et al.Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura[J].Blood,2010,115:29-31.
[27]	Zaja F,Marin L,Chiozzotto M,et al.Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab[J].Am J Hematol,2012,87:321-323.
[28]	Kurtoglu E,Karakus V,Deveci B,et al.Refractory idiopathic thrombocytopenic purpura treated with immunoadsorption using tryptophan column[J].Transfus Apher Sci,2013,48:311-312.